Speech-Language Pathologists in Ft Worth, TX Accepting Medicare

17 Speech-Language Pathologists found. Showing 1 - 17

Kristi Fulton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8850 Elbe Trl, Ft Worth, TX 76118 Phone: 972-219-1200

Linda Willis, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5100 Randol Mill Rd, Ft Worth, TX 76112 Phone: 817-548-3258

Mrs. Amy E Williams, SPEECH LANGUAGE PATH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6801 Dan Danciger Rd, Ft Worth, TX 76133 Phone: 817-294-0350

Ms. Anne Pinkenburg, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6850 Manhattan Blvd Ste 204, Ft Worth, TX 76120 Phone: 817-207-1500    Fax: 817-507-0702

Kimberly Dawn Fowler Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4011 Benbrook Hwy Ste C, Ft Worth, TX 76116 Phone: 817-386-5500

Shelley Davidson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6850 Manhattan Blvd Ste 204, Ft Worth, TX 76120 Phone: 817-507-1500

Sarah Wheeler, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5300 Altamesa Blvd, Ft Worth, TX 76133 Phone: 817-346-1800

Melba A. Moreno-lofgren, S.L.P. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3840 Hulen St Ste 100, Ft Worth, TX 76107 Phone: 817-569-4039

Kaitlyn Mckenzie Davis, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4901 Bryant Irvin Rd N Ste 200, Ft Worth, TX 76107 Phone: 817-738-9866

Bailey Long, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3840 Hulen St, Ft Worth, TX 76107 Phone: 817-569-4039

Anna Gershberg Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 900 W Leuda St, Ft Worth, TX 76104 Phone: 817-332-7003

Kelly Sullivan, MS, CCC/SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1400 8th Ave, Carter Rehabilitation & Fitness Center, Ft Worth, TX 76104 Phone: 817-922-2502    Fax: 817-922-7733

Christine Carter Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7021 Bryant Irvin Rd, Ft Worth, TX 76132 Phone: 817-361-1413

Ms. Carol Diane Edley, MS CCC SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4400 Sweetgum Way, Ft Worth, TX 76133 Phone: 817-294-2227

Leah Rothwell, MA,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Summit Ave, 510, Ft Worth, TX 76102 Phone: 682-730-0009

Katy Shipp Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Summit Ave, Ft Worth, TX 76102 Phone: 817-877-1199

Mrs. Trina Elaine Ard, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5411 Basswood Blvd, Suite 221, Ft Worth, TX 76137 Phone: 817-514-6333

News Archive

FixHepC Buyers Club exposes weakness in Australian healthcare, assists patients to import life saving medication

In one of the greatest advances in medicine in decades, Hepatitis C is now largely curable. Over 200,000 Australians suffer from Hepatitis C. However the US manufacturer, Gilead Sciences Inc is attempting to charge the PBS $84,000 for a 12 week course of medication that costs under $200 dollars to manufacture.

Infants with bronchiolitis are at increased risk of hospitalization for asthma in preschool years

Infants who are admitted to hospital with the common infection bronchiolitis are at increased risk of further emergency hospital admissions for asthma, wheezing and respiratory illness in the first five years of their life.

U.S. biotech company chooses OmniComm's SaaS model for 4 clinical studies

OmniComm Systems, Inc., one of the fastest growing companies in the EDC marketplace, today announced that its TrialMaster suite of applications and IVRS technology has been chosen by a prominent biotechnology company to manage their clinical data management and randomization needs for 4 key clinical trials.

University of Liverpool awarded £2.2 million for genomics hub

The University of Liverpool has been awarded £2.2 million to establish a high-throughput genomic analysis hub for the North of England.

Seroquel XR supplemental NDA recommended for approval

The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) conducted a review of the safety and efficacy of supplemental new drug applications (sNDA) for Seroquel XR (quetiapine fumarate) extended-release tablets proposed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).

Read more Medical News

› Verified 1 days ago